Doctors missing up to 64% sleep apnoea cases


Wednesday, 29 May, 2019



Doctors missing up to 64% sleep apnoea cases

The criteria doctors use to refer patients to a sleep study appear to be insufficient, missing over 60% of patients later found to have clinically relevant obstructive sleep apnoea, according to new research published in the Medical Journal of Australia.

Obstructive sleep apnoea (OSA) affects 9–38% of adults, is associated with high morbidity and mortality, and its health-related and other costs are high.

Until recently, OSA was predominantly managed by sleep specialists. Recent changes to the Medicare Benefits Schedule now allow primary care clinicians to directly refer patients for a sleep study if they have a positive result in at least two categories of the Berlin questionnaire (BQ), or an OSA-50 score of at least 5, or a score of at least 4 on the STOP-Bang questionnaire, if they also have an Epworth sleepiness score (ESS) of 8 or more.

However, according to research led by Professor Shyamali Dharmage, from the Allergy and Lung Health Unit at the University of Melbourne’s School of Population and Global Health, a significant number of OSA patients are being missed.

Dharmage and colleagues analysed data from 424 randomly selected participants in the Tasmanian Longitudinal Health Study with OSA symptoms, who completed OSA screening questionnaires and underwent type 4 sleep studies.

They found that STOP-Bang and OSA-50 correctly identified most participants with clinically relevant OSA, but with poor specificity; the specificity and sensitivity of the BQ were both low. When combined with the criterion ESS ≥8, the specificity of each questionnaire was high, but sensitivity was low. Sensitivity and specificity could be adjusted according to specific needs by varying the STOP-Bang cut-off score together with the ESS ≥8 criterion.

The researchers recommended that the “combined use of the STOP-Bang with different cut-off scores and the ESS facilitates a flexible balance between sensitivity and specificity”.

“Our STOP-Bang/ESS-based decision support tool may assist primary care physicians make objective and uniform decisions regarding OSA assessment and referral.”

Image credit: ©stock.adobe.com/au/Rafael Ben-Ari

Related Articles

Digital pharmacy key to medicine safety and efficacy

Electronic prescriptions and real-time prescription monitoring are among projects tipped to...

Return Your Opioids campaign kicks off

As the TGA launches a new awareness campaign aimed at curbing opioid-related harm, an...

When medicines run dry, what's your backup plan?

What do you do when your hospital pharmacy can't fill a script?


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd